Showing results (561-570 of 657) with videos related to
Sort By:
Pageof 66
Proceedings of the National Academy of Sciences of the United States of America|April 25, 1995
Potent interleukin 3 receptor agonist with selectively enhanced hematopoietic activity relative to recombinant human interleukin 3J W Thomas, C M Baum, W F Hood, et al.OTJR : Occupation, Participation and Health|August 13, 2025
Sleep Disturbance in People With Stroke: Experiences, Coping Strategies, and NeedsTyler R Hood, Eric C Landsness, Carolyn M Baum, et al.British Journal of Cancer|September 1, 1990
Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblastsA A Colletta, L M Wakefield, F V Howell, et al.Oncogene|April 26, 2006
Solution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7O Ohlenschläger, T Seiboth, H Zengerling, et al.Plos One|September 8, 2017
Prevention of vaginal and rectal HIV transmission by antiretroviral combinations in humanized micePhilippe A Gallay, Udayan Chatterji, Aaron Kirchhoff, et al.American Journal of Physiology. Cell Physiology|March 17, 2021
Phosphorylation of ERK and dystrophin S3059 protects against inflammation-associated C2C12 myotube atrophyKristy Swiderski, Christopher J Brock, Jennifer Trieu, et al.Plos One|July 8, 2014
Functional β-adrenoceptors are important for early muscle regeneration in mice through effects on myoblast proliferation and differentiationJarrod E Church, Jennifer Trieu, Radhika Sheorey, et al.BMC Plant Biology|November 4, 2017
Assessment of genetic diversity and yield performance in Jordanian barley (Hordeum vulgare L.) landraces grown under Rainfed conditionsA M Al-Abdallat, A Karadsheh, N I Hadadd, et al.Cancer Research|August 1, 1992
Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatmentA Butta, K MacLennan, K C Flanders, et al.Lancet (London, England)|January 11, 2005
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancerA Howell, J Cuzick, M Baum, et al.Pageof 66